Funds holding DRUGS MADE IN AMERICA ACQUISITION II CORP
ISIN KYG2851K1206 · Cayman Islands
- Fund holders
- 7
- Of which ETFs
- 0 7 other funds
- Value held
- 5M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| The Merger Fund Merger Fund | 414,523 | 4.2M $ | 0.17 % | as of Mar 31, 2026 ↗ |
| JNL Multi-Manager Alternative Fund JNL Series Trust | 22,952 | 230.4K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Virtus Westchester Event-Driven Fund Virtus Event Opportunities Trust | 22,215 | 223K $ | 0.17 % | as of Mar 31, 2026 ↗ |
| Virtus Westchester Credit Event Fund Virtus Event Opportunities Trust | 16,049 | 161.1K $ | 0.19 % | as of Mar 31, 2026 ↗ |
| Global Multi-Strategy Fund Principal Funds, Inc | 10,374 | 104.6K $ | 0.02 % | as of Feb 28, 2026 ↗ |
| JNL/Westchester Capital Event Driven Fund JNL Series Trust | 8,067 | 81K $ | 0.17 % | as of Mar 31, 2026 ↗ |
| The Merger Fund VL Merger Fund VL | 4,207 | 42.2K $ | 0.18 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Virtus Westchester Credit Event Fund Virtus Event Opportunities Trust | 0.19 % | as of Mar 31, 2026 ↗ |
| The Merger Fund VL Merger Fund VL | 0.18 % | as of Mar 31, 2026 ↗ |
| Virtus Westchester Event-Driven Fund Virtus Event Opportunities Trust | 0.17 % | as of Mar 31, 2026 ↗ |
| The Merger Fund Merger Fund | 0.17 % | as of Mar 31, 2026 ↗ |
| JNL/Westchester Capital Event Driven Fund JNL Series Trust | 0.17 % | as of Mar 31, 2026 ↗ |
| JNL Multi-Manager Alternative Fund JNL Series Trust | 0.02 % | as of Mar 31, 2026 ↗ |
| Global Multi-Strategy Fund Principal Funds, Inc | 0.02 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 7 | -1 | 498,387 | -0.6 % |
| 2026Q1 | 8 | +1 | 501,387 | +155.0 % |
| 2025Q4 | 7 | 196,585 |
Cite this page
Titelia. "Funds holding DRUGS MADE IN AMERICA ACQUISITION II CORP". https://titelia.com/en/stocks/drugs-made-in-america-acquisition-ii-corp-KYG2851K1206